Russia starts developing new Covid-19 vaccine against Omicron variant
Image Credit: shortpdia
Russia`s Gamaleya National Research Center of Epidemiology and Microbiology has said it has begun developing a new version of Sputnik vaccine adapted to target the Omicron variant of Covid-19. Gamaleya in a statement on Monday added that the center is studying whether its Sputnik V and Sputnik Light vaccines can neutralise the Omicron variant as it believes, Xinhua news agency reported.